
Germany · Biopharma startup
pluriSelect offers separation technologies for the isolation of cells, proteins, viruses, and bacteria from blood and biological fluids.
Follow pluriSelect and see its new rounds in your feed.Sign up free
Funding reportedLast round: Undisclosed round
Funding, as reported
Add your raise, your deck and your story, and put pluriSelect in front of investors. Or tell us what we have wrong.